https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Curr. Top. Microbiol. Immunol. 2003;276:199-214
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Curr. Top. Microbiol. Immunol. 2003;276:199-2142003-01-01 00:00:002019-02-15 08:37:54Dendritic cell vaccination and viral infection–animal models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Cancer Invest. 2003;21(6):873-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Cancer Invest. 2003;21(6):873-862003-01-01 00:00:002019-02-15 08:44:48The first 1000 dendritic cell vaccinees
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Nat. Med. 2003 Jan;9(1):13-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Nat. Med. 2003 Jan;9(1):13-42003-01-01 00:00:002019-02-15 09:15:22Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-832003-01-01 00:00:002020-06-23 09:43:21Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):285-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):285-942003-01-01 00:00:002003-01-01 00:00:00Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-192002-12-01 00:00:002019-02-15 08:44:50Advances in dendritic cell-based vaccine of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-202002-11-01 00:00:002019-02-15 08:48:26Cancer immunotherapy: stress proteins and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-82002-10-29 00:00:002019-02-15 08:53:33Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-142002-10-01 00:00:002019-02-15 08:37:56Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-62002-10-01 00:00:002002-10-01 00:00:00Dendritic cells in vaccination therapies of malignant diseases
